auto_awesome
Want to know who else bid on this?
ProposalForge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
Medicago inc.Amount
$169.9M
Program
SIF Stream3- AttractionProvince
QCType
Contribution
Agreement Number
033-2020-2021-Q3-815733
Purpose
The Project is in direct response to the global fight against COVID-19. The Project will be undertaken in two stages to (1) develop a plant-derived virus-like particle (VLP) vaccine for the prevention of COVID-19; and (2) establish a large-scale GMP Facility for vaccine and antibody production in Canada.
Medicago inc. × Innovation, Science and Economic Development Canada
3 grants totalling $542.9M
SIF Stream3- Attraction
64 grants totalling $9.5B
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| 1000511515 Ontario Inc. | $700.0M | SIF Stream3- Attraction |
| PowerCo Canada Inc. | $700.0M | SIF Stream3- Attraction |
| Umicore Canada Inc. | $551.3M | SIF Stream3- Attraction |
| FCA Canada Inc. | $529.3M | SIF Stream3- Attraction |
| FCA Canada Inc. | $529.3M | SIF Stream3- Attraction |